JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6876
Expion Energy, Inc. Common Stock
XPON
$4M
| – | – |
0
| – | – |
2023 Q4
1 quarter
|
|
6877
American Shared Hospital Services
AMS
$9.38M
| $27 | ﹤0.01% |
9
-98
| -92% | -$262 |
2023 Q3
2 quarters
|
|
|
HEPA
6878
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
-22
| Closed | -$2.53K | – |
|
|
HQL
6879
abrdn Life Sciences Investors
HQL
$538M
| $27 | ﹤0.01% |
2
-8,103
| -100% | -$112K |
2022 Q4
5 quarters
|
|
6880
Nortech Systems
NSYS
$33M
| $27 | ﹤0.01% |
2
+1
| +100% | +$11 |
2023 Q3
2 quarters
|
|
6881
NexGel
NXGL
$1.7M
| $27 | ﹤0.01% |
+10
| New | +$24 |
2024 Q1
0 quarters
|
|
|
FLZH
6882
DELISTED
FLASH SPORTS & MEDIA HLDG
FLZH
| $27 | ﹤0.01% |
1
| – | – |
2023 Q3
2 quarters
|
|
6883
Xcel Brands
XELB
$4.31M
| $27 | ﹤0.01% |
3
+1
| +50% | +$11 |
2023 Q3
2 quarters
|
|
6884
Yunhong Green CTI Ltd
YHGJ
$7.28M
| $27 | ﹤0.01% |
2
+1
| +100% | +$16 |
2023 Q3
2 quarters
|
|
|
ANEB
6885
DELISTED
Anebulo Pharmaceuticals
ANEB
| $26 | ﹤0.01% |
+9
| New | +$23 |
2024 Q1
0 quarters
|
|
6886
bioAffinity Technologies
BIAF
$3.63M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
6887
Barnwell Industries
BRN
$14.2M
| $26 | ﹤0.01% |
11
+2
| +22% | +$5 |
2023 Q3
2 quarters
|
|
|
DGICB
6888
Donegal Group Class B
DGICB
$618M
| $26 | ﹤0.01% |
2
+1
| +100% | +$14 |
2023 Q3
2 quarters
|
|
6889
Gray Media Inc
GTN.A
$536M
| $26 | ﹤0.01% |
3
+1
| +50% | +$8 |
2023 Q4
1 quarter
|
|
6890
Mannatech
MTEX
$12.8M
| $26 | ﹤0.01% |
3
+1
| +50% | +$9 |
2023 Q3
2 quarters
|
|
|
TLIS
6891
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $26 | ﹤0.01% |
3
+1
| +50% | +$8 |
2023 Q3
2 quarters
|
|
6892
Tonix Pharmaceuticals
TNXP
$153M
| – | – |
0
| – | – |
2024 Q1
0 quarters
|
|
|
VIVK
6893
Vivakor
VIVK
$185K
| – | – |
0
| – | – |
2023 Q4
1 quarter
|
|
|
OPNW
6894
OpenWorld, Inc. Common Stock
OPNW
$72.4M
| $25 | ﹤0.01% |
2
+1
| +100% | +$12 |
2023 Q3
2 quarters
|
|
|
EIGR
6895
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $25 | ﹤0.01% |
5
-1
| -17% | -$6 |
2019 Q1
20 quarters
|
|
6896
Barfresh Food Group
BRFH
$13.9M
| $24 | ﹤0.01% |
20
+8
| +67% | +$10 |
2023 Q3
2 quarters
|
|
|
ISPO
6897
DELISTED
Inspirato
ISPO
| $24 | ﹤0.01% |
6
+2
| +50% | +$8 |
2023 Q3
2 quarters
|
|
6898
NextPlat
NXPL
$23.2M
| $24 | ﹤0.01% |
+2
| New | +$31 |
2024 Q1
0 quarters
|
|
|
SGRP
6899
DELISTED
SPAR Group
SGRP
| $24 | ﹤0.01% |
25
+11
| +79% | +$11 |
2023 Q3
2 quarters
|
|
|
STRR
6900
DELISTED
Star Equity Holdings
STRR
| $24 | ﹤0.01% |
5
+1
| +25% | +$5 |
2023 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.